Screening for Ureaplasma urealyticum infections in the neonate and the association with prematurity.
Ureaplasma urealyticum has been implicated in gynaecological, obstetrical and neonatal pathology. Increased levels of C-reactive protein and total IgM concentrations in cord blood have often been used as a screening method for infectious disease in the fetus and the newborn. Analysis of the isolation rate of U. urealyticum in function of the concentrations of these two parameters in cord blood showed that U. urealyticum was significantly (P less than 0.05) more frequently isolated when CRP was above normal in cord blood. No correlation between the IgM level in the newborn and the presence of U. urealyticum could be established. A significant relationship was found (P less than 0.01) between Ureaplasma isolation in the urine of mother and child on the one hand and gestational age on the other hand, which supports the hypothesis that U. urealyticum may play a role in preterm delivery.
D002097:C-Reactive Protein / Q000032:analysis*; D005260:Female; D005312:Fetal Blood / Q000032:analysis*; D005865:Gestational Age; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis*; D007231:Infant, Newborn; D007234:Infant, Premature; D008403:Mass Screening; D009174:Mycoplasma / Q000302:isolation & purification; D009180:Mycoplasmatales Infections / Q000453:epidemiology / Q000378:metabolism / Q000382:microbiology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000378:metabolism / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000302:isolation & purification; D014509:Ureaplasma / Q000302:isolation & purification*; D014556:Urine / Q000382:microbiology
D007075:Immunoglobulin M; D002097:C-Reactive Protein